Search
Arrowhead Pharmaceuticals Inc
ARWRAdd to Watchlist
81.820USD
+0.780+0.96%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
11.50BMarket Cap
LossP/E TTM
Arrowhead Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Arrowhead Pharmaceuticals Inc is 7.14, ranking 258 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -36.03, which is -237.35% below the recent high of 49.49 and -16519.11% above the recent low of -5988.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
